ARCHIVES

Professional Societes; ASCO’s Strength Is In Its Diversify, Lichtor Says

This article is from The Cancer Letter archive.

Vol. 25 No. 20 | May 21, 1999

Download PDF Visit The Full Archive

Related Articles

Center Review By Panel, NCI Leading To Changes; Hammer Tells NCAB It Faces “Difficult Decision”

December 13, 1984

NSABP Executive Committee Nominates Wolmark To Succeed Fisher As Chairman

October 21, 1994

NCCS Names 7 To Board; FDA Approves Warning Labels for Hormone Therapy

January 17, 2003

FDA’s Young Still Not Satisfied With Distribution Plan

September 9, 1977

Old MSK Grant Reprogrammed, NIC Makes Final 1985 Construction Awards

July 5, 1985

FDA to Require Data On saline Breast, Silcone Testicular Implants

January 29, 1993